Skip to main content
Equibles

Ian Clark

Board Member

Kyverna Therapeutics, Inc. (KYTX)

Board Member

Guardant Health, Inc. (GH)

Equibles does not estimate personal net worth.

Get an email with a short summary when Kyverna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get KYTX alerts

About Ian Clark

Ian Clark is recorded as Board Member at Kyverna Therapeutics, Inc. (KYTX) since January 1, 2021 and Board Member at Guardant Health, Inc. (GH) since January 1, 2017. The newest filing on record that lists Ian Clark as Board Member at Kyverna Therapeutics, Inc. (KYTX) is dated April 13, 2026. The newest filing on record that lists Ian Clark as Board Member at Guardant Health, Inc. (GH) is dated April 28, 2026. Earlier roles on record: Board Member at Tectonic Therapeutic, Inc. (TECX) until June 20, 2024. Tectonic Therapeutic, Inc. reported in an 8-K filed June 20, 2024 that Ian Clark resigned as member of the board of directors, effective June 20, 2024. Guardant Health, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Kyverna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Guardant Health, Inc. includes AmirAli Talasaz (CEO and Board Member), Helmy Eltoukhy (CEO, Chairman and Board Member), Michael Bell (CFO) and 7 others.

“In accordance with the Merger Agreement, immediately prior to the Merger, Gail Farfel, Ph.D., Christopher Paige, Ph.D., Philip J. Vickers, Ph.D., Ian Clark, Annalisa Jenkins, M.B.B.S., F.R.C.P. and Bruce Booth, D.Phil. resigned from the AVROBIO's board of directors and committees of the AVROBIO board of directors on which they respectively served, which resignations were not the result of any disagreements with the Company relating to its operations, policies or practices.”
Tectonic Therapeutic, Inc. Form 8-K, filed June 20, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Guardant Health, Inc.

Leadership on record at Kyverna Therapeutics, Inc.

Recent activity